Compounding of Human Drug Products Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act; Establishment of a Public Docket | Federal Regulations · Congress.wiki

Rulemaking

FDA

RIN Not Assigned

Open for Comments

FDA-2015-N-0030

Compounding of Human Drug Products Under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act; Establishment of a Public Docket

Documents

Comments

197,420

Description

Compounding of Human Drug Products

Key Dates

Comment Period OpensMar 9, 2015

Comment Period ClosesAug 17, 2022

Documents

Type	Title	Posted	Comments	Status
Other	Supplement from Novo Nordisk, Inc.	Apr 29, 2025	--

Comment Statistics

Total Comments

197,420

Keywords

2014-657

Data from Regulations.gov